|
1
|
Jemal A, Murray T, Samuels A, Ghafoor A,
Ward E and Thun MJ: Cancer statistics, 2003. CA Cancer J Clin.
53:5–26. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hunter KD, Parkinson EK and Harrison PR:
Profiling early head and neck cancer. Nat Rev Cancer. 5:127–135.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Marumoto T, Zhang D and Saya H: Aurora-A -
a guardian of poles. Nat Rev Cancer. 5:42–50. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stenoien DL, Sen S, Mancini MA and
Brinkley BR: Dynamic association of a tumor amplified kinase,
Aurora-A, with the centrosome and mitotic spindle. Cell Motil
Cytoskeleton. 55:134–146. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baba Y, Nosho K, Shima K, Irahara N, Kure
S, Toyoda S, Kirkner GJ, Goel A, Fuchs CS and Ogino S: Aurora-A
expression is independently associated with chromosomal instability
in colorectal cancer. Neoplasia. 11:418–425. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kitzen JJ, de Jonge MJ and Verweij J:
Aurora-A kinase inhibitors. Crit Rev Oncol Hematol. 73:99–110.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Milam MR, Gu J, Yang H, Celestino J, Wu W,
Horwitz IB, Lacour RA, Westin SN, Gershenson DM, Wu X and Lu KH:
STK15 F31I polymorphism is associated with increased uterine cancer
risk: A pilot study. Gynecol Oncol. 107:71–74. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ogawa E, Takenaka K, Katakura H, Adachi M,
Otake Y, Toda Y, Kotani H, Manabe T, Wada H and Tanaka F:
Perimembrane Aurora-A expression is a significant prognostic factor
in correlation with proliferative activity in non-small-cell lung
cancer (NSCLC). Ann Surg Oncol. 15:547–554. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang R, Wang JH, Chu XY, Geng HC and Chen
LB: Expression of STK15 mRNA in hepatocellular carcinoma and its
prognostic significance. Clin Biochem. 42:641–647. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang SB, Zhou XB, Zhu HX, Quan LP, Bai JF,
He J, Gao YN, Cheng SJ and Xu NZ: Amplification and overexpression
of Aurora-A in esophageal squamous cell carcinoma. Oncol Rep.
17:1083–1088. 2007.PubMed/NCBI
|
|
11
|
Zhang H, Chen X, Jin Y, Liu B and Zhou L:
Overexpression of Aurora-A promotes laryngeal cancer progression by
enhancing invasive ability and chromosomal instability. Eur Arch
Otorhinolaryngol. 269:607–614. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang LH, Xiang J, Yan M, Zhang Y, Zhao Y,
Yue CF, Xu J, Zheng FM, Chen JN, Kang Z, et al: The mitotic kinase
Aurora-A induces mammary cell migration and breast cancer
metastasis by activating the Cofilin-F-actin pathway. Cancer Res.
70:9118–9128. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sakakura C, Hagiwara A, Yasuoka R, Fujita
Y, Nakanishi M, Masuda K, Shimomura K, Nakamura Y, Inazawa J, Abe T
and Yamagishi H: Tumour-amplified kinase BTAK is amplified and
overexpressed in gastric cancers with possible involvement in
aneuploid formation. Br J Cancer. 84:824–831. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW,
Sahin A, Brinkley BR and Sen S: Tumour amplified kinase STK15/BTAK
induces centrosome amplification, aneuploidy and transformation.
Nat Genet. 20:189–193. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gritsko TM, Coppola D, Paciga JE, Yang L,
Sun M, Shelley SA, Fiorica JV, Nicosia SV and Cheng JQ: Activation
and overexpression of centrosome kinase BTAK/Aurora-A in human
ovarian cancer. Clin Cancer Res. 9:1420–1426. 2003.PubMed/NCBI
|
|
16
|
Weaver KL, Alves-Guerra MC, Jin K, Wang Z,
Han X, et al: NACK is an integral component of the Notch
transcriptional activation complex and is critical for development
and tumorigenesis. Cancer Res. 74:4741–4751. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Archewa P, Pata S, Chotjumlong P,
Supanchart C, Krisanaprakornkit S and Iamaroon A: Akt2 and p-Akt
overexpression in oral cancer cells is due to a reduced rate of
protein degradation. J Investig Clin Dent. Epub ahead of print.
2015.
|
|
18
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gabarra-Niecko V, Schaller MD and Dunty
JM: FAK regulates biological processes important for the
pathogenesis of cancer. Cancer Metastasis Rev. 22:359–374. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
McLean GW, Carragher NO, Avizienyte E,
Evans J, Brunton VG and Frame MC: The role of focal-adhesion kinase
in cancer - a new therapeutic opportunity. Nat Rev Cancer.
5:505–515. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Canel M, Secades P, Rodrigo JP, Cabanillas
R, Herrero A, Suarez C and Chiara MD: Overexpression of focal
adhesion kinase in head and neck squamous cell carcinoma is
independent of fak gene copy number. Clin Cancer Res. 12:3272–3279.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang F, Guo X, Yang G, Rosen DG and Liu J:
AURKA and BRCA2 expression highly correlate with prognosis of
endometrioid ovarian carcinoma. Mod Pathol. 24:836–845. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guan Z, Wang XR, Zhu XF, Huang XF, Xu J,
Wang LH, Wan XB, Long ZJ, Liu JN, Feng GK, et al: Aurora-A, a
negative prognostic marker, increases migration and decreases
radiosensitivity in cancer cells. Cancer Res. 67:10436–10444. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hochwald SN, Nyberg C, Zheng M, Zheng D,
Wood C, Massoll NA, Magis A, Ostrov D, Cance WG and Golubovskaya
VM: A novel small molecule inhibitor of FAK decreases growth of
human pancreatic cancer. Cell Cycle. 8:2435–2443. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang L, Dan HC, Sun M, Liu Q, Sun XM,
Feldman RI, Hamilton AD, Polokoff M, Nicosia SV, Herlyn M, et al:
Akt/protein kinase B signaling inhibitor-2, a selective small
molecule inhibitor of Akt signaling with antitumor activity in
cancer cells overexpressing Akt. Cancer Res. 64:4394–4399. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Feng R, Chen X, Yu Y, Su L, Yu B, Li J,
Cai Q, Yan M, Liu B and Zhu Z: miR-126 functions as a tumour
suppressor in human gastric cancer. Cancer Lett. 298:50–63. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Giet R, Petretti C and Prigent C: Aurora
kinases, aneuploidy and cancer, a coincidence or a real link.
TRENDS in Cell Biology. 15:241–250. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang H, Chen X, Liu B and Zhou L: Effects
of stable knockdown of Aurora kinase A on proliferation, migration,
chromosomal instability, and expression of focal adhesion kinase
and matrix metalloproteinase-2 in HEp-2 cells. Mol Cell Biochem.
357:95–106. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Reiter R, Gais P, Jütting U, Steuer-Vogt
MK, Pickhard A, Bink K, Rauser S, Lassmann S, Höfler H, Werner M
and Walch A: Aurora kinase A messenger RNA overexpression is
correlated with tumor progression and shortened survival in head
and neck squamous cell carcinoma. Clin Cancer Res. 12:5136–5141.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Naruganahalli KS, Lakshmanan M, Dastidar
SG and Ray A: Therapeutic potential of Aurora kinase inhibitors in
cancer. Curr Opin Investig Drugs. 7:1044–1051. 2006.PubMed/NCBI
|
|
31
|
Li DW, Sun YJ, Sun ZF and Dong P:
Involvement of focal adhesion kinase in cellular proliferation,
apoptosis and prognosis of laryngeal squamous cell carcinoma. J
Laryngol Otol. 126:1127–1133. 2012. View Article : Google Scholar : PubMed/NCBI
|
